MedTrace Logo

Anti Free Radical & Anti Inflammatory Effect & Safety of Rebamipide in Chronic Gastritis

NCT00996788 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2013-05-15

No results posted yet for this study

Summary

To study the anti free radical \& inflammatory effect and safety of Rebamipide in patients suffering of dyspepsia due to chronic gastritis.

Conditions

  • Dyspepsia
  • Chronic Gastritis

Interventions

DRUG

Rebamipide

Rebamipide 100 mg tid for 28 days

Sponsors & Collaborators

  • PT Otsuka Indonesia

    lead INDUSTRY

Principal Investigators

  • Aziz Rani, MD · Division of Gastroenterology Department of Internal Medicine - Cipto Mangunkusumo Hospital, Faculty of Medicine University of Indonesia

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00996788 on ClinicalTrials.gov